In breast cancer specifically, cancer stem cell expansion post therapy has been reported37,38 and shown to be dependent on the production of several pro-tumorigenic factors including IL-6, IL-8, and TGFβ18,19,39. This evidence concerns the gene CXCL8 and breast carcinoma.